Advertisement
New Zealand markets closed

  • NZX 50

    11,584.24
    -94.44 (-0.81%)
     

  • NZD/USD

    0.6102
    -0.0015 (-0.24%)
     

  • NZD/EUR

    0.5650
    -0.0005 (-0.09%)
     

  • ALL ORDS

    7,896.10
    -39.60 (-0.50%)
     

  • ASX 200

    7,628.90
    -36.70 (-0.48%)
     

  • OIL

    79.15
    -0.08 (-0.10%)
     

  • GOLD

    2,333.90
    -7.30 (-0.31%)
     

  • NASDAQ

    18,736.75
    -132.69 (-0.70%)
     

  • FTSE

    8,183.07
    -71.11 (-0.86%)
     

  • Dow Jones

    38,441.54
    -411.32 (-1.06%)
     

  • DAX

    18,473.29
    -204.58 (-1.10%)
     

  • Hang Seng

    18,252.32
    -224.69 (-1.22%)
     

  • NIKKEI 225

    38,035.96
    -520.91 (-1.35%)
     

  • NZD/JPY

    95.8750
    -0.4700 (-0.49%)
     

Elanco Animal Health (ELAN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2-min read

Elanco Animal Health Incorporated (ELAN) reported $1.21 billion in revenue for the quarter ended March 2024, representing a year-over-year decline of 4.1%. EPS of $0.34 for the same period compares to $0.45 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.17 billion, representing a surprise of +2.69%. The company delivered an EPS surprise of +30.77%, with the consensus EPS estimate being $0.26.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Elanco Animal Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Total Pet Health: $639 million compared to the $616.09 million average estimate based on three analysts. The reported number represents a change of -5.3% year over year.

  • Revenue- Total Farm Animal: $556 million compared to the $552 million average estimate based on three analysts. The reported number represents a change of -3% year over year.

  • Revenue- Total Contract Manufacturing: $10 million versus the two-analyst average estimate of $8.03 million. The reported number represents a year-over-year change of +11.1%.

View all Key Company Metrics for Elanco Animal Health here>>>

Shares of Elanco Animal Health have returned -11.5% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Elanco Animal Health Incorporated (ELAN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research